STLA IMPORTANT DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Stellantis N.V. Investors to Secure Counsel Before...

Ascletis Reinforces Its Differentiated Obesity Portfolio at American Diabetes Association (ADA) 2026 Scientific Sessions, Showcasing ASC30...

OriCell's GPC3 CAR-T Receives NMPA Clearance for Confirmatory Phase II Trial in Late-Line Advanced Hepatocellular Carcinoma

Antengene Presented First Preclinical Data at EULAR 2026 Showing ATG-207 Promotes Regulatory T Cell Induction and Immune Tolerance

GNI Group to Acquire Ayumi Pharmaceutical Holdings, Expanding Its Position as a Global Biopharmaceutical Company

LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China

Australian Retirees Seek Reliable Monthly Income From Global Private Credit as Inflation Bites and TermPlus Targets Up To 8.50%* Per Annum

Odysight.ai® Establishes At-The-Market (ATM) Program of up to $20 Million to Enhance Financial Flexibility

Entrata Collaborates with OpenAI to Define the Future of Autonomous Property Management

SK Telecom and NVIDIA Build AI Infrastructure to Power Korea’s AI Innovation

NAVER Expands AI Infrastructure With NVIDIA to Serve Surging Global AI Demand

NVIDIA and SK hynix Announce Multiyear Technology Partnership to Advance Memory for AI Factories

Sportradar Group AG (SRAD) Investors: July 17, 2026, Deadline in Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer &...

VolitionRx Announces Pricing of $4.6 Million Public Offering

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Phreesia, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class...

He Predicted Gold at $5,000. Now He Says This $2 Stock Could Be Even Bigger.

MEDP DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important June...

Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications

Novo Nordisk's CagriSema 2.4 mg / 2.4 mg demonstrated significant reduction in HbA1c and weight across multiple studies in the REIMAGINE...

FCM marks 125 years as municipal leaders gather in Edmonton